Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

304
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
304
Selectins01:25

Selectins

3.8K
Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Risk Associated with Tibolone Use in Postmenopausal Women.

Journal of menopausal medicine·2025
Same author

Diminished Ovarian Reserve: A Narrative Review of Etiologies and Possible Therapeutic Approaches.

Journal of menopausal medicine·2025
Same author

Clinical characteristics of endometrioma with and without dysmenorrhea diagnosed by laparoscopy: A retrospective cohort study in a tertiary center.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2024
Same author

Clinical Characteristics of Gynecologic Problems During Childhood in the Korean Population.

Journal of Korean medical science·2023
Same author

Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration.

Scientific reports·2023
Same author

Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer.

Breast cancer research and treatment·2023
Same journal

Elinzanetant: Defining the Role of Dual Neurokinin-1 and Neurokinin-3 Receptor Antagonism for Management of Vasomotor Symptoms in Menopause.

Journal of menopausal medicine·2026
Same journal

Sexual Health Problems and Service Needs of Menopausal Women: A Mixed Method Study in Osun State Nigeria.

Journal of menopausal medicine·2026
Same journal

Assessment of Oral and Emotional Health in Pre-Menopausal and Post-Menopausal Women: A Cross-Sectional Study.

Journal of menopausal medicine·2026
Same journal

Association between Serum Adiponectin and Vitamin D in Obese Pre- and Early Postmenopausal Women: A Cross-Sectional Study.

Journal of menopausal medicine·2026
Same journal

Estrogen Deficiency in Menopause: A Major Contributor to Cartilage Degeneration and Osteoarthritis: A Systematic Review and Meta-Analysis.

Journal of menopausal medicine·2026
Same journal

Sleep Disturbances during Menopause: Mechanisms and Management Approaches.

Journal of menopausal medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K

Tissue-Selective Estrogen Complex and Breast.

Dong Yun Lee1

  • 1Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. dongyun0406.lee@samsung.com.

Journal of Menopausal Medicine
|September 7, 2020
PubMed
Summary
This summary is machine-generated.

Tissue-selective estrogen complex (TSEC), a progestin-free menopausal hormone therapy (MHT), offers a safer alternative for managing menopausal symptoms and preventing bone loss. Studies show TSEC has favorable effects on breast health, supporting its clinical use.

Keywords:
BazedoxifeneBreastConjugated estrogenTissue-selective estrogen complex

More Related Videos

An Ex vivo Model to Study Hormone Action in the Human Breast
12:31

An Ex vivo Model to Study Hormone Action in the Human Breast

Published on: January 8, 2015

11.8K
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.8K

Related Experiment Videos

Last Updated: Dec 9, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K
An Ex vivo Model to Study Hormone Action in the Human Breast
12:31

An Ex vivo Model to Study Hormone Action in the Human Breast

Published on: January 8, 2015

11.8K
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.8K

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology
  • Oncology

Background:

  • Estrogen-progestin therapy was standard for menopausal symptoms but declined due to side effects.
  • Progestin component is linked to adverse MHT effects.
  • Need for progestin-free alternatives prompted development of new therapies.

Purpose of the Study:

  • To review the effects of tissue-selective estrogen complex (TSEC) on breast health.
  • To evaluate TSEC as a progestin-free menopausal hormone therapy (MHT).
  • To assess TSEC's safety and efficacy in postmenopausal women.

Main Methods:

  • Review of preclinical and clinical studies on TSEC.
  • Analysis of TSEC's impact on breast-related outcomes.
  • Evaluation of safety profiles compared to conventional MHT.

Main Results:

  • TSEC, combining conjugated estrogen and bazedoxifene, is approved for vasomotor symptoms and bone loss prevention.
  • Progestin-free MHT with TSEC may offer improved safety regarding breast pain, mammographic density, and cancer incidence.
  • Evidence supports TSEC's beneficial effects on breast tissue.

Conclusions:

  • TSEC represents a significant advancement in progestin-free MHT.
  • The favorable breast profile of TSEC supports its use in clinical practice.
  • Further research may elucidate long-term breast-specific benefits of TSEC.